{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:15:46Z","timestamp":1761513346377},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.cjca.2013.06.013","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T19:30:22Z","timestamp":1379100622000},"page":"1586-1592","source":"Crossref","is-referenced-by-count":3,"title":["Management of Risk Factors Among Ambulatory Patients at High Cardiovascular Risk in Canada: A Follow-up Study"],"prefix":"10.1016","volume":"29","author":[{"given":"Esam A.","family":"Elbarasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun G.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond T.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary K.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel G.","family":"Hackam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence A.","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoly","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2013.06.013_bib1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2013.06.013_bib2","first-page":"1441","article-title":"Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias","volume":"162","author":"Fodor","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2013.06.013_bib3","first-page":"1249","article-title":"The 2000 Canadian recommendations for the management of hypertension: part two-diagnosis and assessment of people with high blood pressure","volume":"17","author":"Zarnke","year":"2001","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.06.013_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0828-282X(09)70715-9","article-title":"2009 Canadian Cardiovascular Society\/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations","volume":"25","author":"Genest","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.06.013_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0828-282X(09)70088-1","article-title":"Management of atherothrombotic risk factors in high-risk Canadian outpatients","volume":"25","author":"Bell","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.06.013_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.108.838466","article-title":"Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals","volume":"120","author":"Waters","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.06.013_bib7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2337\/dc07-2413","article-title":"Burden and rates of treatment and control of cardiovascular disease risk factors in obesity: the Framingham Heart Study","volume":"31","author":"Molenaar","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjca.2013.06.013_bib8","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.06.013_bib9","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ahj.2004.04.034","article-title":"How does the prognosis of diabetes compare with that of established vascular disease? Insights from the Canadian Vascular Protection (VP) Registry","volume":"148","author":"Hackam","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2013.06.013_bib10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.amjmed.2005.11.015","article-title":"Contemporary management of dyslipidemia in high-risk patients: targets still not met","volume":"119","author":"Yan","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2013.06.013_bib11","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0828-282X(07)70882-6","article-title":"Missed opportunities for the secondary prevention of cardiovascular disease in Canada","volume":"23","author":"Hackam","year":"2007","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.06.013_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2013.06.013_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-121-9-199411010-00002","article-title":"Cholesterol and coronary heart disease: predicting risks by levels and ratios","volume":"121","author":"Kinosian","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2013.06.013_bib14","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.97.15.1453","article-title":"Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)","volume":"97","author":"Pedersen","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.06.013_bib15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.CIR.0000153859.66086.85","article-title":"Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting","volume":"111","author":"Mosca","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.06.013_bib16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.amjcard.2005.04.019","article-title":"Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations","volume":"96","author":"Davidson","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2013.06.013_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archinte.160.4.459","article-title":"The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals","volume":"160","author":"Pearson","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2013.06.013_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/euhj.2001.2610","article-title":"Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme","volume":"22","author":"EUROASPIRE II Study Group","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2013.06.013_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2013.06.013_bib20","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199010183231606","article-title":"The value of lowering cholesterol after myocardial infarction","volume":"323","author":"Rossouw","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2013.06.013_bib21","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2013.06.013_bib22","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1161\/01.CIR.92.9.2419","article-title":"Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program","volume":"92","author":"Byington","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.06.013_bib23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2013.06.013_bib24","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/01.CIR.93.10.1796","article-title":"Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study","volume":"93","author":"Pedersen","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.06.013_bib25","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.2337\/diacare.28.12.2901","article-title":"Type 2 diabetes as a \u201ccoronary heart disease equivalent\u201d: an 18-year prospective population-based study in Finnish subjects","volume":"28","author":"Juutilainen","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjca.2013.06.013_bib26","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2337\/diacare.28.7.1588","article-title":"Should diabetes be considered a coronary heart disease risk equivalent?: Results from 25 years of follow-up in the Renfrew and Paisley survey","volume":"28","author":"Whiteley","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjca.2013.06.013_bib27","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/archinte.161.12.1521","article-title":"Temporal trends (1986-1997) in cholesterol level assessment and management practices in patients with acute myocardial infarction: a population-based perspective","volume":"161","author":"Yarzebski","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2013.06.013_bib28","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(00)04235-5","article-title":"Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group","volume":"357","author":"EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events","year":"2001","journal-title":"Lancet"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X13004406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X13004406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T03:08:32Z","timestamp":1563937712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X13004406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0828282X13004406"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2013.06.013","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}